Drug Kinetics – Products

As a great partner for pharmaceutical industry, Sino Biological is proud to announce the launch of anti-payload mAbs FREE trial campaign. You can get anti-MMAE/MMAF mAbs freely, just contact us to apply—let's get started. Move now!

Cresset, announces an extension of the global collaboration with Enamine, in the area of targeted protein degradation (TPD).

The interactions between FcRn and IgG are strongly associated with the development of antibody drugs and targeting FcRn presents an effective therapeutic strategy to reduce serum IgG levels in autoimmune diseases. Using the FcRn Binding Kit (TR-FRET): unleashing the potential of high-throughput antibody drug screening, enabling rapid progress in your research endeavors.

Biora Therapeutics, Inc. has shared positive topline results from its clinical trial of BT-600, an orally administered drug-device combination in development for the potential treatment of ulcerative colitis.

Four new anti-idiotypic antibodies and a new anti-MMAE antibody range support bioanalytical assay development for preclinical research and clinical trials.

The collaborative center will help to lower barriers to RNA innovation and discovery.

Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in rodent samples.

Applied Biophysics Forum promises real-world data from nucleic acid drug delivery researchers.

In a significant stride towards advancing nanoparticle drug delivery manufacturing technology, German pharmatech company, leon-nanodrugs GmbH (LEON), proudly announces a pioneering technical evaluation by CMAC, University of Strathclyde.

Fast-track your ADC journey with our comprehensive suite of high-quality materials for every stage of Antibody-Drug Conjugates development.